1. Japan Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
Mitsubishi Chemical Group Corporation

Mitsubishi Chemical Group Corporation

MTLHY
Mitsubishi Chemical Group CorporationUS flagOther OTC
36.25
USD
- -
- -
9.85BMarket Cap
Mitsubishi Chemical Group Corporation
MTLHY
(Other OTC)

Recent

price

36.25

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
11,124.32
10,880.41
10,475.82
11,879.99
12,436.34
12,094.9
11,530.22
12,937.91
13,503.14
12,607.59
11,468.13
13,994.03
16,298.31
15,419.97
13,871.72
- -
7,863.28
Revenue per Share
293.61
120.35
63.07
109.5
207
175.31
533.67
735.71
596.09
190.41
-26.6
623.39
339.23
420.35
158.2
- -
184.11
Basic EPS, GAAP
609.2
345.87
241.59
142.39
575.13
275.39
651.84
589.43
650.47
760.31
739.72
313.9
260.92
670.17
800.75
- -
426.17
Free Cash Flow per Basic Share
43.47
50.06
55.07
60.1
59.99
70
80.04
135
185.89
200.02
120.02
135.01
149.99
154.98
160
- -
80
Dividend per Share
1,763.21
1,779.75
1,794.54
1,845.78
2,152.36
2,255.95
2,771.04
3,497.95
3,951.68
3,948.15
3,907.99
4,446.61
4,644.09
4,938.68
4,967.69
- -
5,003.22
Book Value per Share
3,116.45
3,177.1
3,249.72
3,457.71
3,940.01
3,866.59
3,955.17
4,308.02
2,841.95
1,139.05
1,562.89
2,428.32
2,819
3,379.67
3,566.44
- -
3,492.25
Tangible Book Value per Share
285
295
295
295
294
293
293
288
284
284
284
284
284
285
285
- -
285
Basic Weighted Avg Shares
3,166,771
3,208,168
3,088,577
3,498,834
3,656,278
3,543,352
3,376,057
3,724,406
3,840,341
3,580,510
3,257,535
3,976,948
4,634,532
4,387,218
3,947,566
3,703,988
2,237,320
Sales/Revenue/Turnover
7.15
4.07
2.92
3.16
4.53
7.19
7.45
8.84
6.98
3.66
0.98
7.09
3.69
5.78
3.39
0.87
5.33
Operating Margin (%)
158,405
157,979
141,382
146,279
172,397
182,656
174,040
178,895
199,332
239,824
243,793
251,469
269,616
275,436
275,933
271,157
139,805
Depreciation Expense
83,581
35,486
18,596
32,248
60,859
51,358
156,259
211,788
169,530
54,077
-7,557
177,162
96,461
119,596
45,020
11,829
52,384
Net Income, GAAP
27.7
41.68
48.41
48.32
41.76
29.3
17.19
19.68
24.78
42.9
30.95
27.88
19.3
25.82
41.49
2,400.28
23.64
Effective Tax Rate (%)
2.64
1.11
0.6
0.92
1.66
1.45
4.63
5.69
4.41
1.51
-0.23
4.45
2.08
2.73
1.14
0.32
2.34
Profit Margin (%)
251,085
307,580
202,882
304,044
241,372
415,015
618,476
604,771
128,541
112,782
305,028
566,823
485,788
466,724
561,402
694,346
513,606
Working Capital
827,977
767,798
653,222
692,729
859,216
872,870
1,116,005
1,025,268
1,138,108
1,555,947
1,696,029
1,748,756
1,642,325
1,595,704
1,612,920
1,503,457
1,558,863
LT Debt
1,114,003
1,144,954
1,203,316
1,314,870
1,602,380
1,596,151
1,698,197
1,919,490
2,025,854
1,450,829
1,571,148
1,844,319
1,988,469
2,275,495
2,284,569
2,414,680
2,257,968
Total Equity
6.61
3.19
1.96
2.27
3.31
5.58
6.29
7.57
5.12
1.86
0.57
5.1
3.32
4.3
1.77
-17.1
2.02
Return on Invested Capital (%)
2.56
0.28
0.1
0.59
1.4
0.54
3.7
5.14
3.78
1
-0.59
4.23
2.12
2.32
0.34
-23.76
0.99
Return on Capital (%)
17.95
6.91
3.53
6.01
10.35
7.94
21.23
23.3
15.91
4.82
-0.68
14.93
7.47
8.78
3.19
0.84
3.75
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
605,307
- -
533,855
LT Borrowings
1,595,704
- -
1,558,863
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,423
- -
1,423
Market Capitalization
1,342,474
1,292,522
1,359,451

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
2,191,636
- -
2,152,336
Cash, Cash Equivalents & STI
377,728
- -
352,092
Accounts Receivable, Net
852,353
- -
761,072
Inventories
799,249
- -
808,784
Total Current Liabilities
1,724,912
- -
1,638,730
Payables & Accruals
- -
- -
- -
ST Debt
605,307
- -
533,855
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.06%
9.15%
5.7%
Free Cash Flow
21.39%
13.08%
-36.74%
Net Income, GAAP
-256.42%
-520.4%
-73.73%
Sales/Revenue/Turnover
1%
3.42%
-6.17%
Total Cash Common Dividend
11.17%
5.62%
-2.25%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,061,242
1,088,656
1,095,242
1,142,078
4,387,218
2025
- -
- -
- -
- -
3,947,566
2026
- -
- -
- -
- -
3,703,988

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
149.55
86.73
128.83
- -
420.35
2025
- -
- -
- -
- -
158.2
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
75
- -
80
- -
154.98
2025
- -
- -
- -
- -
160
2026
- -
- -
- -
- -
- -
Similar Companies
Weifang Yaxing Chemical Co., Ltd. (600319.SS)
PT Eterindo Wahanatama Tbk (ETWA.JK)
Amines & Plasticizers Limited (AMNPLST.BO)
ChinYang Chemical Corporation (051630.KS)
Skotan S.A. (SKT.WA)
Chung Hwa Chemical Industrial Works, Ltd. (1727.TW)
Business
Mitsubishi Chemical Group Corporation is a leading diversified chemical company headquartered in Tokyo, Japan, founded in 1933. It operates primarily in the manufacturing and sale of chemicals, performance products, industrial materials, and healthcare-related products. Its extensive product portfolio includes chemicals such as petrochemicals, basic chemicals, and intermediates; high-performance polymers and engineering plastics; plastic molded and processed products including films and sheets; carbon fibers and composite materials; electronic materials for displays and batteries; inorganic products such as alumina fibers; fibers and textiles; agricultural chemicals; pharmaceutical products; and healthcare materials. The group also provides related services including IT and analytical services. Operations span globally with a strong presence in Asia, the Americas, and Europe. In recent strategic developments, Mitsubishi Chemical Group has divested its pharmaceutical business, Mitsubishi Tanabe Pharma Corporation, selling it to Bain Capital for over $3 billion in early 2025 to sharpen its focus on core chemical businesses. The group has also restructured its holdings by transferring a majority stake in its Indonesian subsidiary PT Mitsubishi Chemical Indonesia to a local company, while retaining a minority stake to optimize market competitiveness specifically in paraxylene and polyester production. Additionally, Mitsubishi Chemical Group has been advancing investments in sustainable and innovative technologies such as molecular recycling commercialization and bio-based lens monomers, alongside expanding production facilities in the US and China. Another key operational change in late 2024 was the sale of its in-house insurance agency business in Japan to Aon to streamline operations. These strategic actions support Mitsubishi Chemical Group's vision of KAITEKI, emphasizing sustainable well-being for people and the planet through material science innovation and business in segments including mobility, digital, medical, and food industries, delivered by around 70,000 employees worldwide.

Company News

APIChatGPT

  • businesswire.com

    Mitsubishi Chemical and Accenture Establish Joint Venture to Drive AI-Enabled Business Reinvention and Operational Transformation

  • seekingalpha.com

    Mitsubishi Chemical Group Corporation (MTLHY) Q4 2026 Earnings Call Transcript

  • defenseworld.net

    Mitsubishi Chemical (OTCMKTS:MTLHY) & Olin (NYSE:OLN) Head to Head Survey

  • defenseworld.net

    Mitsubishi Chemical (OTCMKTS:MTLHY) versus ASP Isotopes (NASDAQ:ASPI) Financial Contrast

  • defenseworld.net

    Brenntag (OTCMKTS:BNTGY) versus Mitsubishi Chemical (OTCMKTS:MTLHY) Critical Survey